ACOR: Acorda Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 15.39
Enterprise Value ($M) 163.96
Book Value ($M) 58.96
Book Value / Share 47.47
Price / Book 0.26
NCAV ($M) -233.66
NCAV / Share -188.12
Price / NCAV -0.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 1.21
Current Ratio 1.59

Balance Sheet (mrq) ($M)
Current Assets 73.73
Assets 366.34
Liabilities 307.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-10 13D/A Davidson Kempner Capital Management Lp 4.53 -38.83

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 1,565 2,404 65.10
2024-03-26 253 3,718 6.80
2024-03-25 2 927 0.22
2024-03-22 718 6,316 11.37

(click for more detail)

Similar Companies
ABUS – Arbutus Biopharma Corporation ACAD – ACADIA Pharmaceuticals Inc.
ACLX – Arcellx, Inc. ACRS – Aclaris Therapeutics, Inc.
ACT – Enact Holdings, Inc.


Financial data and stock pages provided by
Fintel.io